{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T13:32:37Z","timestamp":1768311157731,"version":"3.49.0"},"reference-count":29,"publisher":"BMJ","issue":"5","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Emerg Med J"],"accepted":{"date-parts":[[2018,1,14]]},"published-print":{"date-parts":[[2018,5]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>To determine the effectiveness of prophylactic anticholinergic medications in reducing extrapyramidal symptoms in patients taking acute antiemetics with a dopamine D2 receptor antagonist effect.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Systematic searches of all published studies through March 2017 were identified from PubMed, Cochrane library, Embase, Web of Science and Scopus. Only randomised controlled trials of patients receiving dopamine D2 antagonist antiemetic therapy for acute migraine in which an anticholinergic or placebo was compared were included. Pooled ORs were calculated for incidence of extrapyramidal symptoms and sedation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Four placebo-controlled randomised controlled trials consisting of 737 patients met the inclusion criteria for our meta-analysis. The effect of diphenhydramine differed depending on the method of administration of the antiemetic. When the antiemetic was delivered as a 2\u2009min antiemetic bolus, the odds of extrapyramidal symptoms were significantly reduced in the diphenhydramine group compared with placebo (OR 0.42; 95%\u2009CI 0.22 to 0.81; P=0.01). However, when the antiemetic was given as a 15\u2009min infusion, there was no significant difference in extrapyramidal symptoms with or without diphenhydramine (OR 1.06; 95%\u2009CI 0.58 to 1.91; P=0.85). The lowest incidence of extrapyramidal symptoms was observed in patients receiving a 15\u2009min antiemetic infusion without diphenhydramine prophylaxis (9.8%). In two trials including 351 patients that dichotomously reported sedation scales, diphenhydramine had significantly higher rates of sedation (31.6%vs19.2%, OR 2.01, 95%\u2009CI 1.21 to 3.33; P=0.007).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Prophylactic diphenhydramine reduces extrapyramidal symptoms in patients receiving bolus antiemetic therapy with a dopamine D2 antagonist effect, but not when it is given as an infusion. Because of significantly greater sedation with diphenhydramine, the most effective strategy is to administer the D2 antagonist antiemetic as a 15\u2009min infusion without prophylaxis.<\/jats:p><\/jats:sec>","DOI":"10.1136\/emermed-2017-206944","type":"journal-article","created":{"date-parts":[[2018,2,13]],"date-time":"2018-02-13T16:28:56Z","timestamp":1518539336000},"page":"325-331","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":19,"title":["Effects of prophylactic anticholinergic medications to decrease extrapyramidal side effects in patients taking acute antiemetic drugs: a systematic review and meta-analysis"],"prefix":"10.1136","volume":"35","author":[{"given":"Ryan S","family":"D\u2019Souza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Mercogliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Ojukwu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shawn","family":"D\u2019Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Singles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaymin","family":"Modi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Short","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Donato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2018,2,3]]},"reference":[{"key":"2024052702042662000_35.5.325.1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38281.595718.7C"},{"key":"2024052702042662000_35.5.325.2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0196-0644(05)80201-X","article-title":"The efficacy of metoclopramide in the treatment of migraine headache","volume":"22","author":"Ellis","year":"1993","journal-title":"Ann Emerg Med"},{"key":"2024052702042662000_35.5.325.3","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1989.00390110070015"},{"key":"2024052702042662000_35.5.325.4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13104-016-2342-6","article-title":"Metoclopramide induced acute dystonic reaction: a case report","volume":"10","author":"Tianyi","year":"2017","journal-title":"BMC Res Notes"},{"key":"2024052702042662000_35.5.325.5","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1993.00410120051007"},{"key":"2024052702042662000_35.5.325.6","doi-asserted-by":"publisher","DOI":"10.1136\/emj.2004.014712"},{"key":"2024052702042662000_35.5.325.7","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.2007.057570"},{"key":"2024052702042662000_35.5.325.8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.1992.hed3203143.x"},{"key":"2024052702042662000_35.5.325.9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1365-2125.1987.tb03021.x","article-title":"Preliminary studies of the pharmacokinetics and pharmacodynamics of prochlorperazine in healthy volunteers","volume":"23","author":"Taylor","year":"1987","journal-title":"Br J Clin Pharmacol"},{"key":"2024052702042662000_35.5.325.10","doi-asserted-by":"publisher","DOI":"10.1136\/adc.55.4.310"},{"key":"2024052702042662000_35.5.325.11","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3181f14098"},{"key":"2024052702042662000_35.5.325.12","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1986.01800090025005"},{"key":"2024052702042662000_35.5.325.13","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/pch\/16.9.590","article-title":"Treatment recommendations for extrapyramidal side effects associated with second-generation antipsychotic use in children and youth","volume":"16","author":"Pringsheim","year":"2011","journal-title":"Paediatr Child Health"},{"key":"2024052702042662000_35.5.325.14","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.156.3.412"},{"key":"2024052702042662000_35.5.325.15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2007.00781.x"},{"key":"2024052702042662000_35.5.325.16","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0885-3924(91)90001-K","article-title":"Diphenhydramine for nausea and vomiting related to cancer chemotherapy with cisplatin","volume":"6","author":"Tsavaris","year":"1991","journal-title":"J Pain Symptom Manage"},{"key":"2024052702042662000_35.5.325.17","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(05)80239-8"},{"key":"2024052702042662000_35.5.325.18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557"},{"key":"2024052702042662000_35.5.325.19","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(86)90046-2"},{"key":"2024052702042662000_35.5.325.20","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1111\/jocn.12984","article-title":"Risk of extrapyramidal side effects comparing continuous vs. bolus intravenous metoclopramide administration: a systematic review and meta-analysis of randomised controlled trials","volume":"24","author":"Cavero-Redondo","year":"2015","journal-title":"J Clin Nurs"},{"key":"2024052702042662000_35.5.325.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2008.03.044"},{"key":"2024052702042662000_35.5.325.22","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ajem.2010.10.007","article-title":"A trial of midazolam vs diphenhydramine in prophylaxis of metoclopramide-induced akathisia","volume":"30","author":"Erdur","year":"2012","journal-title":"Am J Emerg Med"},{"key":"2024052702042662000_35.5.325.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2008.08.003"},{"key":"2024052702042662000_35.5.325.24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.annemergmed.2015.07.495","article-title":"Diphenhydramine as adjuvant therapy for acute migraine: an emergency department-based randomized clinical trial","volume":"67","author":"Friedman","year":"2016","journal-title":"Ann Emerg Med"},{"key":"2024052702042662000_35.5.325.25","doi-asserted-by":"publisher","DOI":"10.1067\/mem.2001.113032"},{"key":"2024052702042662000_35.5.325.26","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-12-178"},{"key":"2024052702042662000_35.5.325.27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.332.7547.969"},{"key":"2024052702042662000_35.5.325.28","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1038\/psp.2012.9","article-title":"Pharmacokinetic\u2013pharmacodynamic modeling of severity levels of extrapyramidal side effects with markov elements","volume":"1","author":"Pilla Reddy","year":"2012","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"2024052702042662000_35.5.325.29","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200620050-00004"}],"container-title":["Emergency Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/emermed-2017-206944","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T09:04:39Z","timestamp":1716800679000},"score":1,"resource":{"primary":{"URL":"https:\/\/emj.bmj.com\/lookup\/doi\/10.1136\/emermed-2017-206944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,3]]},"references-count":29,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,4,19]]},"published-print":{"date-parts":[[2018,5]]}},"alternative-id":["10.1136\/emermed-2017-206944"],"URL":"https:\/\/doi.org\/10.1136\/emermed-2017-206944","relation":{},"ISSN":["1472-0205","1472-0213"],"issn-type":[{"value":"1472-0205","type":"print"},{"value":"1472-0213","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,3]]}}}